This content is not available in English

Health Sciences / About / Innovations and patents /

A bracelet that parameterizes Parkinson’s tremor

La enfermedad de Parkinson es el segundo trastorno neurodegenerativo más común después de la enfermedad de Alzheimer. Afecta a alrededor del 3% de la población mundial mayor de 65 años y degenera el sistema nervioso central de manera gradual. Actualmente no existe cura y, loa medicamentos y cirugías capaces de brindar alivio a esta enfermedad, generalmente presentan efectos secundarios graves que pueden ser tan fuertes como la propia enfermedad.

This content is not available in English

This content is not available in English

This content is not available in English

Health Sciences / About / Innovations and patents /

Valve homograft implant for cardiovascular diseases

Dr. María Guadalupe Moreno Treviño developed a valve homograft implant for cardiovascular diseases. This project was registered by CONACYT in 2016.

Along with this project, UDEM’s Bank of Cells, Tissues, and Organs was also set up. It contributes to strengthening national infrastructure for the preservation of cardiovascular tissues.

This content is not available in English

Health Sciences / About / Innovations and patents /

An efficient method to detect polymorphism

Researchers Rafael B. León Cachón, María Guadalupe Moreno Treviño, and Denis Aideé Martínez Treviño developed a method to detect GSTM3 A/B polymorphism in Human DNA samples in 2017. Polymorphism is related to the metabolism of drugs and carcinogens; therefore, it is associated with cancer.

Currently, polymorphism detection is carried out mostly through PCR-nucleotide sequencing and RFLPs. However, this requires long processes that can be costly. This innovation consists of designing TaqMan probes specific to the genetic variants and using another method called PCR in real time.

This content is not available in English

Health Sciences / About / Innovations and patents /

App to diagnose cancer in real time

Universidad de Monterrey graduates Alejandro López, Andrés Garzafox, and Sergio Hurtado, developed Dermapp, a cellphone app that assesses, analyzes, and determines the risk of suffering from skin cancer.

If the app yields a disturbing result, the user can be referred to a specialist to decide on the course of action to be undertaken.

This content is not available in English

This content is not available in English

Health Sciences / About / Achievements and awards /

UDEM receives distinction as first university with a Cardiovascular Tissue Bank

The Health Sciences Division at the Universidad de Monterrey has become the eighth Cardiovascular Tissue Bank nationwide and UDEM is the first university to obtain this distinction bestowed by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS – Federal Commission for Protection against Health Risks).

Out of a total of 498 Tissue Banks registered with the Centro Nacional de Transplantes (CENATRA – National Center for Transplants), at present only seven Heart Banks operate in the country and one of them has partial registration, just for heart valves.

This content is not available in English

Health Sciences / About / Achievements and awards /

The Clinical Simulation Laboratory of the Universidad de Monterrey is an American Heart Association International Training Center

Credits: Archivo UDEM

The Clinical Simulation Laboratory of the Universidad de Monterrey has been officially established as an American Heart Association (AHA) International Training Center. Thus, UDEM has obtained authorization to teach the courses in the Emergency Cardiovascular Care program, as it is now part of the AHA Training Center Network.

This content is not available in English

Health Sciences / About / Research and publications /

Nuevas opciones para tratamientos contra el alzhéimer

Credits: Archivo UDEM

El Dr. Román Vidal Tamayo, profesor e investigador de la UDEM, y el equipo de la Dra. Viviana Zomosa, de la Facultad de Medicina de la UANL, descubrieron una variante que puede ayudar a revertir el proceso de la enfermedad de Alzheimer.

El alzhéimer es una enfermedad cognitiva, pues se caracteriza por problemas de memoria y razonamiento; degenerativa, ya que una vez que empieza el paciente empeora; e incapacitante, pues va a llegar un momento en el que este no va a poder llevar a cabo sus actividades habituales.